Mal Irvine
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Distinctive features of the tumor and immune microenvironment in glioblastoma.
Journal: NPJ precision oncology
Published: August 12, 2025
Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response Biomarkers.
Journal: Cancers
Published: August 17, 2022
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma.
Journal: Nature communications
Published: June 25, 2022
Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling.
Journal: Cancer gene therapy
Published: November 17, 2021
Label-Free Fluorescent Poly(amidoamine) Dendrimer for Traceable and Controlled Drug Delivery.
Journal: Biomacromolecules
Published: April 19, 2019
Preexisting MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patients.
Preexisting MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 06, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026